154 related articles for article (PubMed ID: 31307643)
1. Magnetic resonance texture analysis for the identification of cytokeratin 19-positive hepatocellular carcinoma.
Wang HQ; Yang C; Zeng MS; Rao SX; Ji Y; Weng X; Wang JY; Sheng RF
Eur J Radiol; 2019 Aug; 117():164-170. PubMed ID: 31307643
[TBL] [Abstract][Full Text] [Related]
2. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
[TBL] [Abstract][Full Text] [Related]
3. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
4. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas.
Hu XX; Wang WT; Yang L; Yang ZX; Liang HY; Ding Y; Ji Y; Zeng MS; Rao SX
Eur J Radiol; 2019 Apr; 113():7-14. PubMed ID: 30927962
[TBL] [Abstract][Full Text] [Related]
5. Preoperative identification of cytokeratin 19 status of hepatocellular carcinoma based on diffusion kurtosis imaging.
Chen J; Liu D; Guo Y; Zhang Y; Guo Y; Jiang M; Dai Y; Yao X
Abdom Radiol (NY); 2023 Feb; 48(2):579-589. PubMed ID: 36416905
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
Chen J; Wu Z; Xia C; Jiang H; Liu X; Duan T; Cao L; Ye Z; Zhang Z; Ma L; Song B; Shi Y
Eur Radiol; 2020 Feb; 30(2):1232-1242. PubMed ID: 31529254
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging and diffusion-weighted imaging-based histogram analyses in predicting glypican 3-positive hepatocellular carcinoma.
Zhao J; Gao S; Sun W; Grimm R; Fu C; Han J; Sheng R; Zeng M
Eur J Radiol; 2021 Jun; 139():109732. PubMed ID: 33905978
[TBL] [Abstract][Full Text] [Related]
8. Differentiating Cytokeratin 19 expression of hepatocellular carcinoma by using multi-b-value diffusion-weighted MR imaging with mono-exponential, stretched exponential, intravoxel incoherent motion, diffusion kurtosis imaging and fractional order calculus models.
Guo Y; Chen J; Zhang Y; Guo Y; Jiang M; Dai Y; Yao X
Eur J Radiol; 2022 May; 150():110237. PubMed ID: 35278979
[TBL] [Abstract][Full Text] [Related]
9. Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination.
Shan Q; Chen J; Zhang T; Yan R; Wu J; Shu Y; Kang Z; He B; Zhang Z; Wang J
Abdom Radiol (NY); 2017 Aug; 42(8):2079-2088. PubMed ID: 28337521
[TBL] [Abstract][Full Text] [Related]
10. The value of MRI in predicting hepatocellular carcinoma with cytokeratin 19 expression: a systematic review and meta-analysis.
Qin Q; Deng LP; Chen J; Ye Z; Wu YY; Yuan Y; Song B
Clin Radiol; 2023 Dec; 78(12):e975-e984. PubMed ID: 37783612
[TBL] [Abstract][Full Text] [Related]
11. Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images.
Zhou W; Zhang L; Wang K; Chen S; Wang G; Liu Z; Liang C
J Magn Reson Imaging; 2017 May; 45(5):1476-1484. PubMed ID: 27626270
[TBL] [Abstract][Full Text] [Related]
12. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
[TBL] [Abstract][Full Text] [Related]
13. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
14. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
[TBL] [Abstract][Full Text] [Related]
15. Texture Analysis of Hepatocellular Carcinoma on Magnetic Resonance Imaging: Assessment for Performance in Predicting Histopathologic Grade.
Choi JM; Yu JS; Cho ES; Kim JH; Chung JJ
J Comput Assist Tomogr; 2020; 44(6):901-910. PubMed ID: 32976263
[TBL] [Abstract][Full Text] [Related]
16. Texture Analysis Based on Preoperative Magnetic Resonance Imaging (MRI) and Conventional MRI Features for Predicting the Early Recurrence of Single Hepatocellular Carcinoma after Hepatectomy.
Zhang J; Liu X; Zhang H; He X; Liu Y; Zhou J; Guo D
Acad Radiol; 2019 Sep; 26(9):1164-1173. PubMed ID: 30425000
[TBL] [Abstract][Full Text] [Related]
17. Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma.
Hu X; Wang Q; Huang G; He X; Sparrelid E; Brismar TB; Fan Y
Comput Math Methods Med; 2023; 2023():5424204. PubMed ID: 36814805
[TBL] [Abstract][Full Text] [Related]
18. Grading of hepatocellular carcinoma based on diffusion weighted images with multiple b-values using convolutional neural networks.
Zhou W; Wang G; Xie G; Zhang L
Med Phys; 2019 Sep; 46(9):3951-3960. PubMed ID: 31169907
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma: In Vivo Evaluation of Water Percentage as a Prognostic Biomarker Using Magnetic Resonance Imaging 3D-VIBE Multiecho Dixon.
Wang M; Yuan F; Wei Y; Xia C; Hu F; Song B
Cancer Biother Radiopharm; 2018 Sep; 33(7):300-306. PubMed ID: 30109954
[TBL] [Abstract][Full Text] [Related]
20. Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
Jia GS; Feng GL; Li JP; Xu HL; Wang H; Cheng YP; Yan LL; Jiang HJ
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):303-309. PubMed ID: 28603099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
